Patents Assigned to VIROVAX LLC
  • Antiviral compounds
    Patent number: 11773121
    Abstract: A compound can include the structure of Formula 1, derivative thereof, prodrug thereof, salt thereof, stereoisomer thereof, tautomer thereof, polymorph thereof, or solvate thereof, or having any chirality at any chiral center: R1 includes a hydrogen or a substituent; R2 includes a hydroxyl, hydroxyl-forming prodrug, or hydroxyl-leaving chemical moiety; R3 includes a halogen; and R4 includes a heterocycle. The compound can be an antiviral compound used in antiviral therapies.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: October 3, 2023
    Assignee: VIROVAX LLC
    Inventors: Sunil Abraham David, Naveen Kumar Rayala